Standout Papers

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage I... 1996 2026 2006 2016 2.2k
  1. Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer (1996)
    William P. McGuire, William J. Hoskins et al. New England Journal of Medicine

Immediate Impact

8 by Nobel laureates 14 from Science/Nature 93 standout
Sub-graph 1 of 16

Citing Papers

Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
Epithelial ovarian cancer
2019 Standout
76 intermediate papers

Works of Martin Davidson being referenced

Combination paclitaxel (TaxolR)-cisplatin vs cyclophosphamide-cisplatin as primary therapy in patients with suboptimally debulked advanced ovarian cancer
1997
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
and 2 more

Author Peers

Author Last Decade Papers Cites
Martin Davidson 1067 226 1745 905 22 2.9k
Paul R. Kucera 1337 220 2235 1055 31 3.3k
Thomas L. Klug 719 218 1876 638 33 3.5k
Jacobus Pfisterer 900 231 1833 636 33 2.4k
Eric L. Jenison 583 174 1517 573 37 2.6k
G. Favalli 1231 252 1818 598 45 2.6k
W.J. Hoskins 1122 349 1730 859 49 2.9k
David Guthrie 670 251 1075 673 48 2.3k
Thomas B. Hakes 1494 325 1884 1112 78 3.2k
L M Parker 450 344 1232 734 23 2.6k
C.O. Granai 664 273 1258 501 70 2.6k

All Works

Loading papers...

Rankless by CCL
2026